Comerica Bank
RARE icon

Comerica Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Comerica Bank’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.72M Buy
118,422
+34,711
+41% +$1.14M 0.01% 959
2025
Q3 		$2.52M Buy
83,711
+34,051
+69% +$1.02M 0.01% 1047
2025
Q2 		$1.81M Buy
49,660
+42,308
+575% +$1.53M 0.01% 1195
2025
Q1 		$266K Buy
7,352
+6,049
+464% +$252K ﹤0.01% 2166
2024
Q4 		$54.8K Sell
1,303
-221
-15% -$11K ﹤0.01% 2779
2024
Q3 		$84.7K Buy
1,524
+396
+35% +$20.2K ﹤0.01% 2641
2024
Q2 		$46.4K Sell
1,128
-261
-19% -$11.1K ﹤0.01% 2773
2024
Q1 		$64.9K Buy
1,389
+58
+4% +$2.74K ﹤0.01% 2678
2023
Q4 		$63.6K Buy
1,331
+264
+25% +$10.2K ﹤0.01% 2650
2023
Q3 		$38K Sell
1,067
-1,488
-58% -$59K ﹤0.01% 2786
2023
Q2 		$16 Buy
+2,555
New +$119K ﹤0.01% 308
2021
Q2 		– Sell
-1,998
Closed -$219K – 2358
2021
Q1 		$219K Sell
1,998
-188
-9% -$25.6K ﹤0.01% 2232
2020
Q4 		$307K Buy
2,186
+3
+0.1% +$356 ﹤0.01% 2122
2020
Q3 		$203K Buy
+2,183
New +$181K ﹤0.01% 2188

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Comerica Bank's RARE Position: Q4 2025 in Review

Comerica Bank increased its Ultragenyx Pharmaceutical (RARE) stake by 41% in Q4 2025, buying an estimated $1.14M and bringing the position to 118,422 shares worth $2.72M. The position accounts for 0.01% of the portfolio, ranked #959.

Comerica Bank first reported a position in RARE in Q3 2020 and has held it in 14 quarters since. 288 funds tracked by Wall St. Rank hold RARE as of Q4 2025.

  • Comerica Bank held 118,422 shares of Ultragenyx Pharmaceutical worth $2.72M as of Q4 2025.
  • Comerica Bank bought 34,711 Ultragenyx Pharmaceutical shares in Q4 2025, an estimated $1.14M.
  • Ultragenyx Pharmaceutical made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #959 holding.
  • Comerica Bank first reported a position in Ultragenyx Pharmaceutical in Q3 2020 and has held it in 14 quarters since.
  • 288 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.